Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
STSSW SHARPS TECHNOLOGY INC C/WTS (TO PUR COM)
0.240-0.046-16.08%
Close
02/03 16:00 ET
High
0.280
Open
0.280
Turnover
1.22K
Low
0.240
Pre Close
0.286
Volume
4.72K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Sharps Technology Announces Pricing of $3.8 Million Private Placement Priced at the Market
NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company", "Sharps") (NASDAQ: "STSS" and "STSSW"), an innovative medical device and drug delivery Company offering patented,
Sharps Technology Ships First Containers of Safety Syringes to Nephron Pharmaceuticals for Commercialization
First product shipped from Sharps' facility in Hungary and first to support the Nephron Pharmaceuticals distribution and sales collaboration Sharps anticipates 1.3 million units to be commercially av
Sharps Technology Inc. to Introduce New Specialized Prefillable Syringe Systems in 2023
High-Value specialized prefillable syringe systems to accelerate revenue growth in 2023 and beyond Company to launch next generation specialty polymer-based syringe products for the healthcare market
Sharps Technology Begins Manufacturing at Its Hungary Facility for the Company's Innovative Syringe Products
Company now transitions from a pre-revenue research & development start-up to a revenue generating manufacturing company Shipments to commence by the end of the year to support the recently announced distribution
Sharps Technology and Nephron Pharmaceuticals Sign Distribution Agreement for Its Innovative Syringe Products
Company anticipates products to be available in the first quarter of 2023 with initial revenue from this agreement expected in the first half of the year Strengthens the collaboration between Sharps a
Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. Announce Manufacturing and Research Partnership
Partnership focused on developing innovative manufacturing, product development, and customer support as the Company prepares to launch its proprietary InjectEZ syringe productWEST COLUMBIA, S.C. and
Sharps Technology Completes Acquisition of Safegard Medical Syringe Manufacturing Facility
NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company") (NASDAQ: "STSS" and "STSSW"), an innovative medical device company offering patented, best-in-class, single use smart safety syringe products, is pleased to announce th
Sharps Technology Announces Letter to Shareholders
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company") (NASDAQ: "STSS" and "STSSW"), is an innovative medical device company offering patented, best-in-class, single use smart safety syringe products, published a letter to
Why Is Sharps Technology (STSS) Stock in the Spotlight Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Medical syringe company Sharps Technology is on the move today. Here's what investors need to know about STSS stock. The post Why Is Sharps Technology (STSS) Stock in the Spotlight Today? appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
Sharps Technology, Inc. Announces Closing of $16 Million Initial Public Offering
NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company") (NASDAQ: "STSS" and "STSSW"), an innovative medical device company offering patented, best-in-class, single use s
Company Overview
More
Sharps Technology, Inc. is a pre-revenue medical device company. It designs and patents various safety syringes and is seeking commercialization by manufacturing and distributing its products. The company was founded by Alan Blackman and Barry B. Berler in 2017 and is headquartered in Melville, NY.
CEO： Mr. Robert M. Hayes
Market： NASDAQ
Listing Date： 04/14/2022
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet